BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30900666)

  • 1. Immunohistochemical expression of cyclooxygenase-2 in oral squamous cell carcinoma.
    Thomas N; Krishnapillai R; Bindhu PR; Thomas P
    Indian J Dent Res; 2019; 30(1):102-106. PubMed ID: 30900666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase and cyclooxygenase-2 gene and protein expressions during progression of oral epithelial dysplasia to carcinoma.
    Nagatsuka H; Siar CH; Tsujigiwa H; Naomoto Y; Han PP; Gunduz M; Sugahara T; Sasaki A; Nakajima M
    Ann Diagn Pathol; 2012 Oct; 16(5):354-61. PubMed ID: 22575501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclo-oxygenase-2 expression in oral squamous cell carcinoma.
    Seyedmajidi M; Shafaee S; Siadati S; Khorasani M; Bijani A; Ghasemi N
    J Cancer Res Ther; 2014; 10(4):1024-9. PubMed ID: 25579548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-1 and COX-2 expression in feline oral squamous cell carcinoma.
    Hayes A; Scase T; Miller J; Murphy S; Sparkes A; Adams V
    J Comp Pathol; 2006; 135(2-3):93-99. PubMed ID: 16952367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MMP-1 in histopathological different grades of oral squamous cell carcinoma and in normal buccal mucosa - an immunohistochemical study.
    George A; Ranganathan K; Rao UK
    Cancer Biomark; 2010; 7(6):275-83. PubMed ID: 21694466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of COX2 expression between oral squamous cell carcinoma, leukoplakia and normal mucosa.
    Amirchaghmaghi M; Mohtasham N; Mozaffari PM
    J Contemp Dent Pract; 2012 Mar; 13(2):205-9. PubMed ID: 22665749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Implication of Survivin Expression in Oral Squamous Cell Carcinoma-An Immunohistochemical Study.
    Ajithkumar M; Murali CR; Vani NV
    J Contemp Dent Pract; 2019 May; 20(5):577-581. PubMed ID: 31316021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cytosolic phospholipase A2 and cyclooxygenase 2 and their significance in human oral mucosae, dysplasias and squamous cell carcinomas.
    Zhang S; Du Y; Tao J; Wu Y; Chen N
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(4):242-8. PubMed ID: 18467819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of cyclooxygenase (COX)-2 in oral squamous cell carcinoma--evidence for COX-2 induction by areca quid ingredients in oral keratinocytes.
    Tang DW; Lin SC; Chang KW; Chi CW; Chang CS; Liu TY
    J Oral Pathol Med; 2003 Oct; 32(9):522-9. PubMed ID: 12969226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2--An Imperative Prognostic Biomarker in Oral Squamous Cell Carcinoma--An Immunohistochemical Study.
    Byatnal AA; Byatnal A; Sen S; Guddattu V; Solomon MC
    Pathol Oncol Res; 2015 Sep; 21(4):1123-31. PubMed ID: 25962348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer.
    Palani J; Lakshminarayanan V; Kannan R
    Indian J Dent Res; 2011; 22(2):362. PubMed ID: 21891916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase isozymes in oral squamous cell carcinoma:a real-time RT-PCR study with clinic pathological correlations.
    Pannone G; Sanguedolce F; De Maria S; Farina E; Lo Muzio L; Serpico R; Emanuelli M; Rubini C; De Rosa G; Staibano S; Macchia L; Bufo P
    Int J Immunopathol Pharmacol; 2007; 20(2):317-24. PubMed ID: 17624243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of osteopontin expression in oral squamous cell carcinoma.
    Jeyasivanesan DL; Mohamed SP; Pandiar D; Basheer S
    Indian J Dent Res; 2019; 30(4):539-543. PubMed ID: 31745049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The expressions of cyclooxygenase-2 (Cox-2),VEGF in oral squamous cell carcinoma and precancerous lesions and their significances].
    Sun XJ; Ma J; Zhang H; Wang XK; Li JH
    Shanghai Kou Qiang Yi Xue; 2005 Apr; 14(2):173-6. PubMed ID: 15886845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Matrix Metalloproteinase-10 at Invasive Front of Squamous Cell Carcinoma and Verrucous Carcinoma in the Oral Cavity.
    Kadeh H; Saravani S; Heydari F; Keikha M; Rigi V
    Asian Pac J Cancer Prev; 2015; 16(15):6609-13. PubMed ID: 26434883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 expression in oral squamous cell carcinoma.
    Pannone G; Bufo P; Caiaffa MF; Serpico R; Lanza A; Lo Muzio L; Rubini C; Staibano S; Petruzzi M; De Benedictis M; Tursi A; De Rosa G; Macchia L
    Int J Immunopathol Pharmacol; 2004; 17(3):273-82. PubMed ID: 15461861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of polo-like kinase 1 in oral squamous cell carcinoma and oral submucous fibrosis.
    Vittal K; Pandian SS; Joseph LD; Raj SG
    Indian J Dent Res; 2018; 29(2):171-175. PubMed ID: 29652009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2 and DNA topoisomerase II alpha in precancerous and cancerous lesions of the oral mucosa.
    Segawa E; Sakurai K; Kishimoto H; Takaoka K; Noguchi K; Hashitani S; Hirota S; Urade M
    Oral Oncol; 2008 Jul; 44(7):664-71. PubMed ID: 17996482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment.
    DiBernardi L; Doré M; Davis JA; Owens JG; Mohammed SI; Guptill CF; Knapp DW
    Prostaglandins Leukot Essent Fatty Acids; 2007 Apr; 76(4):245-50. PubMed ID: 17383864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.